Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

$7.46
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$7.39
$7.48
50-Day Range
$6.83
$7.87
52-Week Range
$6.82
$14.70
Volume
570,356 shs
Average Volume
1.58 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.27%
Price Target
N/A
BAYRY stock logo

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

BAYRY Stock Price History

BAYRY Stock News Headlines

Caucasian Garden Worker Preparing Grass Lawn Fertilizer. Spring Time Fertilizing Job.
ScottsMiracle-Gro Stock Blooms After Investor Day Optimism (BAYRY)
Lawn and garden products manufacturer ScottsMiracle-Gro Co. (NYSE: SMG) stock surged on its Investor Day update ahead of fiscal Q3 2024 earnings release.
Obama wins Presidential debate
When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”
Obama wins Presidential debate
When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”
Why Bayer Leverkusen want to sign Joël Matip
See More Headlines
Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/13 Dividend
4/29/2024
Dividend Payable
5/13/2024
Last Earnings
5/14/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
Employees
99,723
Year Founded
1863

Profitability

Net Income
$-3,183,040,000.00
Pretax Margin
-3.41%

Debt

Sales & Book Value

Annual Sales
$51.55 billion
Cash Flow
$3.93 per share
Book Value
$10.44 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.04

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. William N. Anderson (Age 58)
    Chairman of the Management Board & CEO
    Comp: $9.16M
  • Mr. Wolfgang U. Nickl (Age 55)
    CFO & Member of Management Board
    Comp: $2.15M
  • Mr. Heiko W. J. Schipper (Age 55)
    Member of Management Board & President of the Consumer Health Division
    Comp: $2.11M
  • Mr. Stefan Oelrich (Age 56)
    Head of the Pharmaceuticals Division & Member of the Board of Management
    Comp: $2.11M
  • Mr. Rodrigo Santos (Age 51)
    Member of Management Board & President of the Crop Science Division
    Comp: $2.35M
  • Ms. Heike Prinz (Age 60)
    Chief Talent Officer, Labor Director & Member of Management Board
    Comp: $1.44M
  • Mr. Julio Triana (Age 58)
    Member of Management Board & President of Consumer Health Division
  • Dr. Sebastian Guth Ph.D.
    Chief Operating Officer
  • Dr. Jost Reinhard (Age 52)
    Head of Investor Relations
  • Mr. Michael Preuss
    Head of Communications, Government Relations and Corporate Brand

BAYRY Stock Analysis - Frequently Asked Questions

How have BAYRY shares performed this year?

Bayer Aktiengesellschaft's stock was trading at $9.23 at the beginning of 2024. Since then, BAYRY stock has decreased by 19.2% and is now trading at $7.46.
View the best growth stocks for 2024 here
.

How were Bayer Aktiengesellschaft's earnings last quarter?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its earnings results on Tuesday, May, 14th. The company reported $0.77 earnings per share for the quarter. The firm had revenue of $14.95 billion for the quarter. Bayer Aktiengesellschaft had a negative net margin of 6.70% and a positive trailing twelve-month return on equity of 17.57%.

Does Bayer Aktiengesellschaft have any subsidiaries?

Bayer Aktiengesellschaft subsidiaries include Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and others.

How do I buy shares of Bayer Aktiengesellschaft?

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BAYRY) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners